Related Experiment Video
Updated: May 5, 2026

08:34
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
50.7K
Significant Improvement in High Myopic Anisometropic Amblyopia Treated With Repeated Low-Level Red-Light (RLRL)
Qiu-Jian Zhu1, Jian-Jun Liu1, Lan-Jun Niu1
1Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, Jiangsu, China.
The American Journal of Case Reports
|March 15, 2026
Summary
Low-level red-light therapy shows promise for treating high myopic anisometropic amblyopia. This novel approach improved visual acuity and reduced eye length in a young patient, suggesting potential for future myopia control strategies.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Myopia Research
Background:
- High myopic anisometropic amblyopia presents a significant challenge for traditional treatments.
- Existing interventions like spectacles, occlusion, and atropine have limited success in correcting refractive imbalance and controlling myopia progression.
Purpose of the Study:
- To investigate the efficacy of repeated low-level red-light therapy (RLRLT) in managing high myopic anisometropic amblyopia.
- To assess RLRLT's impact on both visual acuity and refractive error in a pediatric case.
Main Methods:
- A case report involving a 5-year-old male diagnosed with high myopic anisometropic amblyopia.
- Treatment involved full correction spectacles combined with RLRLT over a 3-year follow-up period.
- Refractive error, best-corrected visual acuity (BCVA), and axial length were monitored.
Main Results:
- The highly myopic eye showed significant improvement: refractive error shifted from -7.75 D to -4.75 D, and BCVA recovered to 20/20.
- Axial length in the affected eye reduced by 1.01 mm (from 27.79 mm to 26.78 mm).
- The fellow eye remained relatively stable.
Conclusions:
- Repeated low-level red-light therapy demonstrated potential in simultaneously normalizing visual acuity and reducing axial length in high myopic anisometropic amblyopia.
- This case suggests RLRLT as a potential novel therapeutic option, warranting further investigation.
- Larger controlled trials are necessary to confirm efficacy and understand underlying mechanisms before clinical adoption.

